ERBB2 and neoplasm: From the 414 patients, age, cT, pathological tumor size, pathological invasive tumor size, pT, hormonal receptor status, HER2 status, Ki-67 LI, subtype, NG, Ly, histological type, pN, pStage, and SUV parameters (SUVmax1, SUVmax2, and ΔSUVmax%) were acquired (Table 1).